Golimumab
From IDWiki
- Humanized monoclonal antibody targeting TNF
- Indications including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
- Adverse effects include URTI, sinusitis, bronchitis, viral infections (including hepatitis B reactivation), superficial fungal infections, invasive fungal infections, tuberculosis
- Also elevated ALT, local injection site reactions, hypertension, dizziness, paresthesia, constipation
